We would like to inform you that the Board of Directors of the Company has at its meeting held today i.e. 11.11.2020 inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended 30.09.2020. The same were also reviewed by the Audit Committee in its meeting held earlier on 11.11.2020.
Panacea Biotec: Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30 2020
November 11, 2020
Download PDF
Panacea Biotec
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month